Charite Universitätsmedizin Berlin
Berlin, 10117, Germany
NCT Number: NCT02008604
The aim of the study is to verify the hypothesis that the microbial colonisation of the gut is changed in patients after stroke and that the gut microbiome of severely affected stroke patients differs from that of patients with only a short disruption of blood circulation in the brain (transient ischemic attack, TIA). For this, the composition of gut microbiota in stool samples will be analyzed by 454 pyrosequencing. Further, the correlation of stroke-associated changes in the microbiome with immunological parameters will be analyzed.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Berlin, 10117, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: change between day 1, day 4, day 7, day 14 after stroke
The composition of the intestinal metagenome / microbiome will be determined by analyzing the 16S rRNA by 454 Pyrosequencing.
Time frame: days 1, 4, 7 after stroke
Analysis of correlation between changes in microbiome (most changed group of bacteria, e.g. lactobacilli) with changes in immunological parameters (e.g. HLA-DR, IL-6, IL-10, CD4-lymphocytes from blood samples).
Charite University, Berlin, Germany
Other
Influence of Stroke on the Composition of Intestinal Microbiota (GUTSTROKE)
Acronym: GUTSTROKE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02341664
Angina, Angina Pectoris
Little Rock, Arkansas, United States
View Trial DetailsNCT01807793
Brain Diseases, Brain Ischemia
Cleveland, Ohio, United States
View Trial DetailsNCT01445613
Amaurosis Fugax, Blindness
Santa Clara, California, United States
View Trial DetailsNCT06943586
Brain Diseases, Brain Ischemia
Birmingham, Alabama, United States
View Trial Details